Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alimta plus cisplatin in first-line gastric cancer
NCT00415168Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2006
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in gastric cancer (GC), sponsored by Eli Lilly and Company. Started Dec 2006; status: completed.
02
Drugs
pemetrexed
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00415168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00415168.